invasive pneumococcal disease in Fiji: Clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine

Fiona Russell, Jonathan Carapetis, Lisi Tikoduadua, Reginald Chandra, Anna Seduadua, Catherine Satzke, Jan Pryor, Eka Buadromo, Lepani Waqatakirewa, Edward (Kim) MULHOLLAND

    Research output: Contribution to journalArticle

    Abstract

    Invasive pneumococcal disease (IPD) epidemiology and the potential impact of the pneumococcal conjugate vaccine in Fiji are documented. The annual incidence was 26.5 and 10.9 in those aged <5 and <55 years per 100,000, respectively. The case fatality rate was 9.4% and 67% in <5 and >65 year olds, respectively. One pneumococcal death and case would be prevented in <5 years olds for every 1930 and 128 infants vaccinated with 7vPCV, respectively. � 2010 by Lippincott Williams & Wilkins.
    Original languageEnglish
    Pages (from-to)870-872
    Number of pages3
    JournalPediatric Infectious Disease Journal
    Volume29
    Issue number9
    Publication statusPublished - 2010

    Fingerprint Dive into the research topics of 'invasive pneumococcal disease in Fiji: Clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine'. Together they form a unique fingerprint.

    Cite this